Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed to support decision making. A countrywide mass vaccination campaign with the use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine (CoronaVac) was conducted in Chile starting on February 2, 2021.

Matéria Original

Anterior

Mapping the human genetic architecture of COVID-19

Próxima

Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia